Corton Capital’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-58,488
Closed -$354K 480
2024
Q2
$354K Buy
+58,488
New +$361K 0.19% 138
2023
Q4
Sell
-11,927
Closed -$87.2K 569
2023
Q3
$87.2K Sell
11,927
-1,778
-13% -$14.8K 0.04% 397
2023
Q2
$143K Buy
+13,705
New +$132K 0.07% 373

Other funds holding ANGO

Corton Capital's ANGO Position: Q3 2024 in Review

Corton Capital sold out of AngioDynamics (ANGO) in Q3 2024, closing a stake of 58,488 shares — an estimated $354K sold.

Corton Capital first reported a position in ANGO in Q2 2023 and held it in 3 quarters. The position peaked at $354K in Q2 2024. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2024.

  • Corton Capital reported no remaining AngioDynamics position as of Q3 2024 after selling out during the quarter.
  • Corton Capital sold 58,488 AngioDynamics shares in Q3 2024, an estimated $354K.
  • Corton Capital first reported a position in AngioDynamics in Q2 2023 and held it in 3 quarters.
  • Corton Capital's AngioDynamics position peaked at $354K in Q2 2024.
  • 138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2024.

Based on Corton Capital's 13F filing for Q3 2024, filed 14 Nov 2024.